These authors contributed equally to this work.
Version of Record online: 15 MAY 2013
Copyright © 2013 American Association for the Study of Liver Diseases
Volume 58, Issue 1, pages 43–53, July 2013
How to Cite
Schieck, A., Schulze, A., Gähler, C., Müller, T., Haberkorn, U., Alexandrov, A., Urban, S. and Mier, W. (2013), Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts . Hepatology, 58: 43–53. doi: 10.1002/hep.26211
Potential conflict of interest: A.A. is shareholder in Myr-GmbH, licensee of Myrcludex B. S.U. is co-applicant and co-inventor on patents protecting HBVpreS-derived lipopetides (Myrcludex B) for the use of HBV/HDV entry inhibitors. S.U., W.M., and U.H. are co-inventors on patent applications protecting the use of HBVpreS-derived lipopeptides as vehicels for liver-specific drug delivery.
Supported by the Bundesministerium für Bildung und Forschung (BMBF), “Innovative Therapieverfahren,” grant number 01GU0702, and Vision 7 GmbH.
- Issue online: 24 JUN 2013
- Version of Record online: 15 MAY 2013
- Accepted manuscript online: 4 JAN 2013 02:39PM EST
- Manuscript Accepted: 6 NOV 2012
- Manuscript Received: 11 JUL 2012
Additional Supporting Information may be found in the online version of this article.
|HEP_26211_sm_SuppFig1.tif||1301K||Supporting Information Figure 1.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.